Filter
1818
Filtered Results: 1818
Text search:
pharmaceutical
products
Featured
Recommendations
166
New Publications
507
Language
Document type
No document type
916
Studies & Reports
355
Guidelines
278
Manuals
94
Strategic & Response Plan
78
Fact sheets
41
Training Material
27
Situation Updates
12
Resource Platforms
9
Infographics
4
Brochures
2
Online Courses
2
Countries / Regions
Kenya
71
Global
70
Ethiopia
62
India
57
Nigeria
40
Western and Central Europe
38
South Africa
38
Sierra Leone
36
Uganda
33
Liberia
33
Ghana
30
Rwanda
29
Nepal
26
Tanzania
26
Namibia
26
Malawi
24
Zambia
24
Ukraine
21
Philippines
19
Africa
19
Bangladesh
19
Zimbabwe
15
Latin America and the Carribbean
15
Cambodia
14
Eastern Europe
14
Indonesia
14
Myanmar / Burma
14
Lesotho
13
South–East Asia Region
13
Eswatini/ Swaziland
12
Syria
10
Botswana
10
West and Central Africa
9
Eastern Europe and Central Asia
9
Congo, Democratic Republic of
8
East and Southern Africa
7
Burkina Faso
6
Guinea
6
Asia
6
Senegal
5
Haiti
5
Venezuela
5
Germany
5
South Sudan
5
Thailand
4
Benin
4
Cameroon
4
Albania
4
Russia
4
Pakistan
4
North Macedonia
3
China
3
Fiji
3
Laos
3
Mozambique
3
USA
3
Jordan
3
Middle East and North Africa
3
Western Pacific Region
3
North America
3
Vietnam
3
Sudan
3
Mali
3
Tajikistan
2
Serbia
2
Kyrgyzstan
2
Afghanistan
2
Peru
2
Jamaica
2
United Kingdom
2
Lebanon
2
Papua New Guinea
2
Brazil
2
Moldova
2
Egypt
2
Georgia
2
Central African Republic
2
Madagascar
2
Timor Leste/ East Timor
1
Australia
1
Kazakhstan
1
Iran
1
Niger
1
Uzbekistan
1
Malaysia
1
Mongolia
1
Bulgaria
1
Armenia
1
Ireland
1
Saudi Arabia
1
Gabon
1
Japan
1
Denmark
1
Maldives
1
Southern Africa
1
Sri Lanka
1
Yemen
1
Angola
1
Libya
1
Bhutan
1
Iraq
1
Somalia
1
Ecuador
1
Authors & Publishers
Publication Years
Category
Countries
716
Clinical Guidelines
128
Public Health
95
Key Resources
90
Women & Child Health
51
Pharmacy & Technologies
38
Capacity Building
12
Annual Report MEDBOX
1
Toolboxes
Pharmacy
195
AMR
180
COVID-19
127
TB
85
HIV
84
Mental Health
82
NTDs
58
Rapid Response
56
Planetary Health
54
Global Health Education
39
NCDs
36
Caregiver
35
Health Financing Toolbox
34
Ebola & Marburg
33
Conflict
29
Specific Hazards
13
Refugee
12
Disability
10
Natural Hazards
9
Polio
9
Cholera
3
Social Ethics
3
Zika
3
Cardiovascular disease is a major cause of disability and premature death throughout the world, and contributes substantially to the escalating costs of health care. The underlying pathology is atherosclerosis, which develops over many years and is usually advanced by the time symptoms occur, genera...
This document sets out, therefore, to explain the socioeconomic value of investing in the fight against NTDs and highlights priorities for global investment attention. Our work was guided by the need not only for
additional funding and funders but also for the need to understand the current funding...
Global Campaign Against Epilepsy
Integrating the prevention and control of noncommunicable diseases in HIV/AIDS, tuberculosis, and sexual and reproductive health programmes: implementation guidance
Guidelines for drinking-water quality: Fourth edition incorporating the first and second addenda
recommended
Guidance has been updated on a number of chemicals: asbestos, bentazone, chromium, iodine, manganese, microcystins, nickel, silver, tetrachloroethene and trichloroethene. Guidance has also been added for chemicals not previously assessed in the Guidelines: anatoxin-a and analogues, cylindrospermopsi...
A two-week mission was conducted by WASH and quality UHC technical experts from WHO headquarters and supported by the WHO Ethiopia Country Office (WASH and health systems teams) in July 2016, to understand how change in WASH services and quality improvements have been implemented in Ethiopia at nati...
The burden of diabetes is enormous, positioning it as one of the main challenges facing public health today. Currently, it is estimated that 62 million people are living with diabetes in the Region of the Americas and projections show its prevalence will continue rising over the following years. The...
This action plan for the Kingdom Saudi Arabia to combat antimicrobial resistance has been formulated in the line of the WHO five objectives. It addresses the need for effective “one health” approach involving coordination among numerous national sectors and actors, including human and veterinary...
The handbook on supply chain management for HIV/AIDS commodities was written to assist program managers to plan and implement day–to-day management of all drugs and medical supplies for an HIV/AIDS program. Many of the suggested techniques described in this handbook are helpfu...
In 2017, 3.6 million of the estimated 10 million people with TB worldwide were “missed” by national TB programmes (NTPs). Two thirds of them are thought to access TB treatment of questionable quality from public and private providers who are not engaged by the NTP. The quality of care provided i...
Second Generation, WHO Country Cooperation Strategy, 2010–2015, Namibia
Using the WHO model list of essential medicines to update a national essential medicines list
Since 1977, WHO has been working with countries to design the package of essential medicines as an integral component of treatment within the continuum of care, developing and disseminating the Model List ...
Call to action by the Global Leaders Group on Antimicrobial Resistance on reducing antimicrobial discharges from food systems, manufacturing facilities and human health systems into the environment.
Evaluation report
April 2013
Evaluation report
This report is part of the overall Ukrainian National AIDS programme evaluation conducted
in September 2012
The revised guidelines contain recommendations for specific administrative, environmental controls and respiratory protection, following the assessment made by an external group of experts convened as members of the Guideline Development Group. Moreover, these guidelines focus on interventions speci...
The report reflects on the trends, achievements and challenges in global health over the past decade during which Dr Margaret Chan has been Director-General of WHO. It discusses the role of WHO in dealing with such issues as the rise of noncommunicable diseases, leaps in life expectancy, and emergin...
Interagency Guidelines - This revised Interagency List of Essential Medicines for Reproductive Health presents
the current international consensus on rational selection of essential reproductive health medicines. The list is intended to support decisions regarding the production, quality assurance...
The new WHO recommendations for the treatment of isoniazid-resistant, rifampicin-susceptible TB are based upon a review of evidence from patients treated with such regimens by a Guideline Development Group in conformity with WHO requirements for evidence-based policies.
